Selected article for: "low expression and lung kidney"
Author: Ao-Xiang Guo; Jia-Jia Cui; Qian-Ying OuYang; Li He; Cheng-Xian Guo; Ji-Ye Yin
Title: The clinical characteristics and mortal causes analysis of COVID-19 death patients
  • Document date: 2020_4_15
    • ID: dtlwjndn_40
    Snippet: In order to explain the clinical features of death patients, we combined the clinical features with the expression of ACE2 and TMPRSS2. TMPRSS2 had a high expression in more organs such as lung, liver and kidney, but had a low expression in heart. ACE2 was highly expressed in heart. Therefore, the key target controlling the invasion of SARS-CoV-2 in different organs may be different. And TMPRSS2 seems had a wider expression and may be more import.....
    Document: In order to explain the clinical features of death patients, we combined the clinical features with the expression of ACE2 and TMPRSS2. TMPRSS2 had a high expression in more organs such as lung, liver and kidney, but had a low expression in heart. ACE2 was highly expressed in heart. Therefore, the key target controlling the invasion of SARS-CoV-2 in different organs may be different. And TMPRSS2 seems had a wider expression and may be more important for patients' infection. Besides, a recent study has reported that a TMPRSS2 inhibitor approved for clinical use could block SARS-CoV-2 from entering cells and might constitute a treatment option [4].

    Search related documents:
    Co phrase search for related documents
    • kidney liver and patient infection: 1, 2, 3, 4, 5, 6
    • kidney liver and recent study: 1, 2, 3, 4, 5
    • kidney liver lung and low expression: 1, 2
    • kidney liver lung and patient infection: 1, 2
    • kidney liver lung and recent study: 1
    • kidney liver lung organ and recent study: 1
    • low expression and patient infection: 1
    • low expression and recent study: 1, 2, 3, 4, 5
    • low expression and SARS invasion: 1, 2
    • low expression and treatment option: 1
    • low expression and wide expression: 1, 2, 3, 4
    • patient infection and recent study: 1, 2, 3, 4, 5, 6, 7, 8
    • patient infection and SARS block: 1, 2
    • patient infection and SARS invasion: 1
    • patient infection and treatment option: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • recent study and SARS invasion: 1, 2
    • recent study and treatment option: 1
    • SARS block and treatment option: 1, 2
    • SARS invasion and treatment option: 1